Natco Pharma Ltd. (NATCOPHARM) - Financials, balance sheet (quarterly)

1,035.099976 INR

2.35

0.23%

Last update Jul 18, 3:29 PM IST

Market closed

Day range

1,035.099976

1,030.44995

1,054.90002

Previous close

1,032.75

Open

1,039.59998

Access this stock data via API

Natco Pharma Ltd.

1,035.10

2.35

0.23%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Sep 2023
Total assets	86.3B	82.4B	69.1B	62.5B
Current assets	52.7B	50.0B	40.2B	33.5B
Cash	—	—	641M	—
Cash equivalents	—	—	63M	—
Cash and cash equivalents	1.2B	1.0B	704M	1.0B
Other short term investments	28.0B	23.6B	17.1B	11.1B
Accounts receivable	12.5B	14.4B	11.9B	11.2B
Other receivables	94M	101M	796M	89M
Inventory	7.7B	7.7B	7.0B	7.1B
Prepaid assets	—	—	2.7B	—
Restricted cash	—	—	31M	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	3.3B	3.2B	2.8B	3.0B
Non current assets	33.6B	32.4B	28.8B	29.0B
Properties	24.3B	23.0B	503M	22.7B
Land and improvements	—	—	3.7B	—
Machinery furniture equipment	—	—	18.3B	—
Construction in progress	2.3B	2.3B	1.4B	836M
Leases	—	—	—	—
Accumulated depreciation	—	—	-10.6B	—
Goodwill	3.2B	2.9B	2.5B	2.5B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	2.1B	1.8B	1.4B	1.4B
Investments and advances	—	—	—	—
Other non current assets	490M	584M	694M	481M
Total liabilities	10.2B	10.9B	10.5B	9.6B
Current liabilities	9.4B	10.1B	9.7B	8.8B
Accounts payable	2.7B	3.1B	2.4B	3.7B
Accrued expenses	—	—	—	—
Short term debt	2.7B	2.0B	3.8B	2.4B
Deferred revenue	—	—	—	—
Tax payable	790M	1.2B	323M	673M
Pensions	—	—	1.0B	—
Other current liabilities	1.2B	1.8B	488M	739M
Non current liabilities	750M	792M	804M	822M
Long term provisions	656M	695M	709M	681M
Long term debt	46M	51M	53M	62M
Provision for risks and charges	—	—	—	—
Deferred liabilities	2M	2M	2M	46M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	358M	358M	358M	358M
Retained earnings	—	—	44.7B	—
Other shareholders equity	—	—	—	—
Total shareholders equity	76.1B	71.6B	58.5B	52.9B
Additional paid in capital	—	—	12.0B	—
Treasury stock	—	—	—	—
Minority interest	53M	69M	0	0